Should SARS CoV-2 infection be considered an independent risk factor for Pneumocystis jirovecii pneumonia? Emerging data after two years of pandemic from a single center experience / Buonomo, Antonio Riccardo; Viceconte, Giulio; Pinchera, Biagio; Scotto, Riccardo; Zappulo, Emanuela; Foggia, Maria; Gentile, Ivan. - In: REVIEWS ON RECENT CLINICAL TRIALS. - ISSN 1574-8871. - 17:3(2022), pp. 220-222. [10.2174/1574887117666220511123826]

Should SARS CoV-2 infection be considered an independent risk factor for Pneumocystis jirovecii pneumonia? Emerging data after two years of pandemic from a single center experience

Buonomo, Antonio Riccardo;Viceconte, Giulio;Pinchera, Biagio;Scotto, Riccardo;Zappulo, Emanuela;Foggia, Maria;Gentile, Ivan
2022

2022
Should SARS CoV-2 infection be considered an independent risk factor for Pneumocystis jirovecii pneumonia? Emerging data after two years of pandemic from a single center experience / Buonomo, Antonio Riccardo; Viceconte, Giulio; Pinchera, Biagio; Scotto, Riccardo; Zappulo, Emanuela; Foggia, Maria; Gentile, Ivan. - In: REVIEWS ON RECENT CLINICAL TRIALS. - ISSN 1574-8871. - 17:3(2022), pp. 220-222. [10.2174/1574887117666220511123826]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/905068
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact